2009•Unpublished venueRequires access

Effect of repaglinide on type 2 diabetes

QU Dao-liang

Open publisher page 0 citations

Abstract

Objective:To investigate the effects of repaglinide on type 2 diabetes and side effects of hypoglycemia.Methods:One hundred and twenty-four patients with type 2 diabetes were divided randomly into 3 groups,patients in group A were treated with repaglinide,patients in group B were treated with repaglinide and metformin,and patients in group C were treated with repaglinide and α glucosidase inhibitor;the therapy course was 12 weeks;effect of blood glucose control and side effects were observed and compared.Results:Avarage fasting blood glucose 2 hours postprandial blood glucose decrease in patients of group A,B and C were 23.5%,32.6% and 21.8%,32.5 % and 15.7%,29.8 % respectively.Conclusion:Repaglinide alone or combined with other medication can significantly lower fasting blood glucose and postprandial blood glucose of patients with type 2 diabetes,and no hypoglycemia and other serious adverse reactions occure.

About this research paper

What this paper is about

Objective:To investigate the effects of repaglinide on type 2 diabetes and side effects of hypoglycemia.Methods:One hundred and twenty-four patients with type 2 diabetes were divided randomly into 3 groups,patients in group A were treated with repaglinide,patients in group B were treated with repaglinide and metformin,and patients in group C were treated with repaglinide and α glucosidase inhibitor;the therapy course was 12 weeks;effect of blood glucose control and side effects were observed and compared.Results:Avarage fasting blood glucose 2 hours postprandial blood glucose decrease in patients of group A,B and C were 23.5%,32.6% and 21.8%,32.5 % and 15.7%,29.8 % respectively.Conclusion:Repaglinide alone or combined with other medication can significantly lower fasting blood glucose and postprandial blood glucose of patients with type 2 diabetes,and no hypoglycemia and other serious adverse reactions occure.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the effects of repaglinide on type 2 diabetes and side effects of hypoglycemia.Methods:One hundred and twenty-four patients with type 2 diabetes were divided randomly into 3 groups,patients in group A were treated with repaglinide,patients in group B were treated with repaglinide and metformin,and patients in group C were treated with repaglinide and α glucosidase inhibitor;the therapy course was 12 weeks;effect of blood glucose control and side effects were observed and compared.Results:Avarage fasting blood glucose 2 hours postprandial blood glucose decrease in patients of group A,B and C were 23.5%,32.6% and 21.8%,32.5 % and 15.7%,29.8 % respectively.Conclusion:Repaglinide alone or combined with other medication can significantly lower fasting blood glucose and postprandial blood glucose of patients with type 2 diabetes,and no hypoglycemia and other serious adverse reactions occure.

Key concepts: Repaglinide, Medicine, Postprandial, Hypoglycemia, Metformin, Internal medicine, Type 2 diabetes, Diabetes mellitus

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of repaglinide on type 2 diabetes — Research Paper | ScholarLens